Administrative/Regulatory
Sep. 3, 2010
Allergan to Pay $600 Million Fine
Irvine-based Allergan Inc. and the U.S. Department of Justice announced a settlement on Sept. 1 in which the company will pay $600 million in fines for a practice known as off-label marketing in relation to the drug Botox.
Daily Journal Staff Writer
Irvine-based Allergan Inc. and the U.S. Department of Justice announced a settlement on Sept. 1 in which the company will pay $600 million in fines for a practice known as off-label marketing in relation to the drug Botox.
King & Spalding partners Stephen S. Cowen in Atlanta and Paul D. Clement in Washington, D.C. represented Allergan during the Justice Department investigation o...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In